BioDuro-Sundia, a drug discovery and development services company, has appointed Haijun Dong, Ph.D., as Chief Executive Officer.   Dong replaces Cyrus K. Mirsaidi, who most recently led the company through its 2020 integration, establishing BioDuro-Sundia as a leading CRDMO in the industry, with more than 2,000 employees and operations in seven cities across China and the U.S.   The executive team, now led by Dong, will continue to support all aspects of drug discovery, development, and manu...